Teva Pharmaceuticals and IBM partner to build global e-Health solutions on the IBM Watson Health Cloud
- Details
- Category: Development
IBM (NYSE: IBM) Watson Health and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that Teva has been selected as its first Foundational Life Sciences Partner for the Watson Health Cloud. As part of this new strategic partnership, Teva becomes the first global pharmaceutical company to tap the power of the Watson Health Cloud to benefit patients and healthcare providers across geographies.
Increasing placebo responses over time, in the U.S. only
- Details
- Category: Research
A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage. Surprisingly, however, the analysis of clinical trials conducted since 1990 found that the increase in placebo responses occurred only in trials conducted wholly in the U.S.; trials conducted in Europe or Asia showed no changes in placebo responses over that period.
The Nobel Prize in Physiology or Medicine 2015
- Details
- Category: Development
The Nobel Assembly at Karolinska Institutet has today decided to award the 2015 Nobel Prize in Physiology or Medicine with one half jointly to William C. Campbell and Satoshi Ōmura for their discoveries concerning a novel therapy against infections caused by roundworm parasites and the other half to Youyou Tu for her discoveries concerning a novel therapy against Malaria.
Study shows new 'driver' to assess cancer patient survival and drug sensitivity
- Details
- Category: Research
Cancer specialists have long looked at genetic mutations and DNA copy changes to help predict patient survival and drug sensitivity. A study led by The University of Texas MD Anderson Cancer Center has opened up yet another avenue for understanding the biological reasons why some people live longer or respond better to treatment - RNA editing events.
Researchers find genes that shut down HIV-1
- Details
- Category: Research
A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating HIV-1. The two studies, published online in Nature, show that the host cell membrane proteins SERINC5 and SERINC3 greatly reduce the virulence of HIV-1 by blocking the ability of the virus to infect new cells.
Decision aids help patients with depression feel better about medication choices
- Details
- Category: Research
Choosing the right antidepressant can be a daunting task. With so many choices and such unpredictability in their individual effects, patients with depression often spend months or years casting about for the right medication, while clinicians are often uneasy or unwilling to offer options other than their preferred prescriptions.
Post-diagnosis aspirin improves survival in all gastrointestinal cancers
- Details
- Category: Research
Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations have been analysed at the same time; previously, only one type of cancer, usually colorectal, was studied. The results of the study, involving nearly 14,000 patients, may lead to new insights regarding the use of aspirin in GI cancer say the researchers.
More Pharma News ...
- Antidepressants plus blood-thinners slow down brain cancer
- Two-drug combination shows promise against one type of pancreatic cancer
- Stanford team re-engineers virus to deliver therapies to cells
- Reanalysis of antidepressant trial finds popular drug ineffective & unsafe for adolescents
- Study highlights possible knowledge gap over effects of some diabetes drugs
- Immune system may be pathway between nature and good health
- Cocoa flavanols lower blood pressure and increase blood vessel function in healthy people